"Designing Growth Strategies is in our DNA"

Collagen Fillers Market Size, Share & Industry Analysis, By Source (Human, Porcine, and Others), By Application (Scar Treatment, Wrinkle Correction Treatment, Lip Enhancement, Restoration of Volume/Fullness, and Others), By End User (Specialty & Dermatology Clinics, Hospitals & Clinics, and Others), and Regional Forecast, 2025-2032

Last Updated: November 24, 2025 | Format: PDF | Report ID: FBI113755

 

KEY MARKET INSIGHTS

Play Audio Listen to Audio Version

The global collagen fillers market size was valued at USD 48.5 million in 2024. The market is projected to grow from USD 49.9 million in 2025 to USD 76.9 million by 2032, exhibiting a CAGR of 6.4% during the forecast period. Asia Pacific dominated the collagen fillers market with a market share of 80.41% in 2024. 

Collagen fillers are increasingly used in dermatological and cosmetic applications due to their ability to improve facial aesthetics and non-invasive nature. These products are derived from bovine, porcine, or human sources and are used to restore volume, reduce wrinkles, and enhance facial contours. Rising awareness of anti-aging procedures, advancements in biomaterials, and the surge in aesthetic clinics are driving market expansion.

In recent years, the market is witnessing an active involvement of leading players in the development of innovative fillers using collagen. This is majorly driven by the increasing demand for natural products to rejuvenate the skin in rapidly developing countries coupled with a surge in the demand for natural look among the general population. Additionally, a rising desire to match with the beauty standards is also contributing to the increasing adoption of collagen dermal fillers across the world.

Some of the key players operating in the market include Sunmax Biotechnology Co., Ltd., EURORESEARCH s.r.l., and SEWON E&C CO., LTD. These companies have well-established products in key regions such as Europe and Asia Pacific.

MARKET DYNAMICS

MARKET DRIVERS

Rising Demand for Collagen Fillers in Rapidly Developing Countries Boosts Market Expansion

One of the significant factors propelling the collagen fillers market growth is a substantial rise in the demand for collagen-based dermal fillers. The strong adoption trends for these products in the rapidly expanding markets such as South Korea, China, and other countries, especially in the Southeast Asia region is primarily driving the market growth. For the past several years, these countries have been at the forefront of the aesthetic market and have witnessed strong adoption of new technologies in dermal fillers, including collagen-based fillers. This is due to the fact that advances in collagen sourcing and formulation – including non-animal and recombinant human collagen are overcoming past drawbacks such as short duration and risk of allergic reaction.

  • For instance, according to MAYPHARM CO., the South Korean company that launched the Skincolla collagen filler, an increasing number of customers are adopting collagen dermal fillers that provide a ‘subtle look’.

MARKET RESTRAINTS

Strong Competition from Existing Products to Hamper Market Growth

Despite recent market developments, the strong presence of technologically advanced existing products hampers the growth for newer products. With technological advancements, collagen-based products are being replaced by hyaluronic acid fillers and others, leading to a rapid decrease in the popularity of collagen-based products. The hyaluronic acid based fillers have effectively addressed several concerns relating to the efficacy and side effects associated with collagen-based fillers. Thus, collagen dermal fillers face a strong competition from alternative products.

MARKET OPPORTUNITIES

Strategic Initiatives by Industry Players to Offer Lucrative Market Growth Opportunities

Non-animal-derived collagen and safer bio-engineered variants are replacing traditional animal-based products to minimize immune reactions. With this shifting focus toward collagen filler resurgence, the leading operating players in the market are undertaking various strategic initiatives to gain a competitive edge in this space. Some of these strategies include new product launches, improved injectability, longer duration, and partnerships between operating entities.

  • In February 2021, a collaboration between Abbvie Inc. and CollPlant Biotechnologies Ltd. is one example of a strategic initiative by the operating players. Through this partnership, Abbvie Inc. aims to enter into collagen dermal fillers space using CollPlant’s innovative technology.

MARKET CHALLENGES

Stringent Regulatory Landscape to Cause Hindrances to Market Growth

Traditionally, the use of collagen dermal fillers was associated with a set of concerns, especially bovine collagen fillers, due to beliefs that they may cause certain allergic and other adverse reactions. Risks such as allergic reactions, tissue damage, and infection, especially from bovine sourced collagen dermal fillers, continue to concern both the providers and the consumers. Hence, this has naturally led to strict regulatory oversight on collagen dermal fillers, leading to a stifled product development history in the past. 

COLLAGEN FILLERS MARKET TRENDS

Focus on Personalized Aesthetic Solutions Represented as One of the Prominent Market Trends

In recent years, the focus on aesthetic treatments among the general population has surged, especially among young adults. The growing popularity of customized skin treatments that combine collagen dermal fillers with laser therapies or micro-needling is gaining traction. This is one of the most prevalent trends witnessed in the market. These fillers fit well into multi-modality anti-aging regimens because they are safe to combine with energy devices and other injectables. The trend toward full-facial rejuvenation creates an opportunity for collagen fillers to be used alongside toxins, HAs, and thread lifts as part of a comprehensive plan.

Download Free sample to learn more about this report.

Segmentation Analysis

By Source

Human Sourced Segment to Dominate the Market Due to Its Strong Product Base

In terms of source, the market is segmented into human, porcine, and others.

In 2024, the human segment held the leading market position and is anticipated to maintain its dominance throughout the forecast period. Increasing demand for these dermal fillers owing to their high biocompatibility coupled with the rising new product launches by the operating players are some of the prominent factors driving the segment growth.

  • For instance, COLLADEW is a collagen filler approved by the Korean Food and Drug Administration (KFDA) and is made with human-derived atelocollagen.

On the other hand, the porcine segment is also expected to grow moderately during the forecast period. This growth is due to the fact that porcine derived collagen resembles human collagen and is safer compared to bovine derived collagen.

By Application

High Number of Individuals Seeking Wrinkle Correction Treatment Boosted Segment Growth

On the basis of application, the market is segmented into lip enhancement, scar treatment, wrinkle correction treatment, restoration of volume/fullness, and others.

In 2024, the wrinkle correction treatment segment dominated the market with the largest share. Factors supporting this dominance include growing concern of the aging population about their physical appearance and wrinkle-free skin, and increasing penetration of major companies operating in this space. In addition, the introduction of new products in this category also supplemented the segment’s growth.

  • For instance, Therafill is one of the products based on collagen that is used for wrinkle correction treatment.

On the other hand, the lip enhancement segment is also growing due to the increasing number of procedures among the patient population. This has resulted in a growing demand for dermal fillers in the market. This has led key players to launch novel fillers with lip enhancement indications in the market.

By End User

Patients Opting for Specialized Facilities in Dermatology Clinics to Drive Segment Growth

Based on end user, the market is categorized into specialty & dermatology clinics, hospitals & clinics, and others.

In 2024, the specialty & dermatology clinics segment captured the dominating share of the global market. The growth is due to several factors including high preference of patients for these settings owing to the availability of all the required and specialized facilities in them. Thus, high patient flow for various dermal filler procedures is driving the segment’s growth.

  • For instance, according to a 2023 report published by the International Society of Aesthetic Plastic Surgery (ISAPS), 20.1% cosmetic procedures were performed in an office facility in Brazil.

On the other hand, the hospitals and clinics segment is also growing considerably during the forecast period. The growth is due to the increasing number of hospitals & clinics resulting in a growing number of procedures performed in these settings.

COLLAGEN FILLERS MARKET REGIONAL OUTLOOK

By region, the market is studied across Europe, Asia Pacific, North America, Latin America, and the Middle East & Africa.

Asia Pacific

Asia Pacific Collagen Fillers Market Size, 2024 (USD Million)

To get more information on the regional analysis of this market, Download Free sample

In 2024, Asia Pacific captured the dominating collagen fillers market share and is likely to uphold its position over the study period. This region is anticipated to be the fastest-growing market with South Korea, China, and India at the forefront of product adoption. This is due to the rising beauty standards and availability of affordable treatment options in these countries. Additionally, the majority of the companies offering collagen fillers are based in Asian countries, which further boosts the regional market growth.

  • For instance, Sunmax Biotechnology Co., Ltd. is one of the leading companies based in Taiwan and has approvals for its collagen products in China and Taiwan.

Europe

Europe accounted for the second-largest market share in 2024. Some of the factors responsible for the region’s growth include the presence of emerging players with innovative product offerings and the increasing number of dermal filler procedures among individuals in key European countries. Furthermore, a supporting regulatory body in the region is another factor contributing to the market growth.

  • For instance, Nithya is a collagen-based product manufactured by EURORESEARCH s.r.l. – an Italian company. The product is CE marked and has been available on the European market since 2016.

North America

The North American market is anticipated to gain a considerable share of the market in the coming years. Currently, no approved product is available in the market in the region. The major players in the dermal fillers market, such as Allergen Aesthetics have withdrawn their collagen-based products long ago due to the introduction of advanced dermal fillers. However, in the near future, the market is expected to witness some developments, such as new product launches by operating players.

U.S.

The U.S. is expected to dominate the North America market in the forecast period. Growing demand for these dermal fillers among patients is resulting in the growing focus of key players on undertaking strategic initiatives to re-enter the market.

Latin America & Middle East Africa

Latin America and the Middle East & Africa have a relatively low collagen filler market share. However, the regional markets are anticipated to witness a steady growth throughout the forecast. This is mainly due to the rising penetration of operating players in these regions, which will lead to increasing product availability.

COMPETITIVE LANDSCAPE

Key Market Players

Strong Brand Presence Coupled with Strategic Initiatives to Boost Market Presence of Leading Companies

The global market space for collagen fillers characterizes a diverse competitive landscape, comprising small and regional players offering low-cost alternatives, which creates pricing pressures.

Currently, the prominent players in the market include Sunmax Biotechnology Co., Ltd., EURORESEARCH s.r.l., and SEWON E&C CO., LTD. These companies have a strong portfolio with product approvals in various countries, and wider adoption of their brands across the world through online distribution channels.

Other significant players operating in the market include CSD, Taumed, DA Korea, Quiver Medic, and MAYPHARM CO. These companies are focusing on expanding their market presence through various strategic initiatives.

LIST OF KEY COLLAGEN FILLERS COMPANIES PROFILED

KEY INDUSTRY DEVELOPMENTS

  • June 2025: CollPlant Biotechnologies revealed that the European Patent and Trademark Office has approved a patent application concerning the company’s regenerative breast implant and injectable filler candidates, which are being developed for the reconstructive and aesthetic procedures markets, respectively.
  • February 2025: MAYPHARM CO. launched SKINCOLLA, the first recombinant human collagen filler in the global market. This product integrates hyaluronic acid with Demulcent Type I recombinant collagen to provide a dual-action approach to improve skin hydration, elasticity, and texture.
  • February 2021: CollPlant Biotechnologies Ltd. and Abbvie Inc. signed a global commercialization agreement for dermal and soft tissue fillers. This agreement combined CollPlant’s proprietary collagen production technology with Allergan/AbbVie’s filler development and marketing.
  • April 2019: Sunmax Biotechnology Co., Ltd. received approval for its Sunmax FACIALGAIN Collagen Implant with Lidocaine from China’s regulatory body – NMPA.

REPORT COVERAGE

The global collagen fillers market report provides an in- depth analysis of the industry. It focuses on key facts such as the overview of the product types, regulatory scenarios by key countries, reimbursement scenarios by key countries, overview of new product launches/approvals, and pipeline analysis. In addition, it includes detailed insights into market dynamics, new product & service launches, and key industry developments such as mergers, partnerships, & acquisitions.

To gain extensive insights into the market, Download for Customization

Report Scope & Segmentation

ATTRIBUTE

DETAILS

Study Period

2019-2032

Base Year

2024

Estimated Year 

2025

Forecast Period

2025-2032

Historical Period

2019-2023

Growth Rate

CAGR of 6.4% from 2025-2032

Unit

Value (USD Million)

Segmentation

By Source

  • Human
  • Porcine
  • Others

By Application

  • Scar Treatment
  • Wrinkle Correction Treatment
  • Lip Enhancement
  • Restoration of Volume/Fullness
  • Others

By  End User

  • Specialty & Dermatology Clinics
  • Hospitals & Clinics
  • Others

By Region

  • North America (By Source, Application, End User, and Country)
    • U.S.  
    • Canada  
  • Europe (By Source, Application, End User, and Country/Sub-Region)
    • U.K.  
    • Germany  
    • France  
    • Spain  
    • Italy  
    • Scandinavia  
    • Ukraine  
    • Rest of Europe  
  • Asia Pacific (By Source, Application, End User, and Country/Sub-Region)
    • Japan  
    • China  
    • India  
    • Australia  
    • South Korea  
    • Thailand  
    • Taiwan  
    • Rest of Asia Pacific  
  • Latin America (By Source, Application, End User, and Country/Sub-Region)
    • Brazil  
    • Mexico  
    • Chile  
    • Colombia
    • Rest of Latin America
  • Middle East & Africa (By Source, Application, End User, and Country/Sub-Region)
    • Egypt
    • Iran
    • Turkey
    • Lebanon
    • UAE
    • Saudi Arabia
    • South Africa
    • Rest of the Middle East & Africa


Frequently Asked Questions

Fortune Business Insights says that the global market size was USD 48.5 million in 2024 and is projected to reach USD 76.9 million by 2032.

In 2024, the market in Asia Pacific stood at USD 39.0 million.

Growing at a CAGR of 6.4%, the market will exhibit steady growth during the forecast period.

In terms of application, wrinkle correction treatment segment is leading the market.

Increase in the demand of collagen fillers in high income countries, surge in the demand for ‘natural look’ and increased accessibility to all consumer groups are the major factors driving the markets growth.

Sunmax Biotechnology Co., Ltd., EURORESEARCH s.r.l., and SEWON E&C CO., LTD. are some of the leading players in the global market.

Asia Pacific dominated the market in 2024.

The significantly increasing awareness about aesthetic beauty and recent new product launches are driving the adoption of the products.

Seeking Comprehensive Intelligence on Different Markets?Get in Touch with Our Experts Speak to an Expert
  • 2019-2032
  • 2024
  • 2019-2023
  • 163
Download Free Sample

    man icon
    Mail icon
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Healthcare Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann